Longbing Ling
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
Papers in
-
- RNA Interference and Gene Delivery 11
- Lipid Membrane Structure and Behavior 6
- Advanced biosensing and bioanalysis techniques 2
- Cancer therapeutics and mechanisms 2
- Retinoids in leukemia and cellular processes 2
- Biomaterials 13
- Nanoparticle-Based Drug Delivery 13
- Co-authors
- Xinsong Li (17 shared papers)Yawei Du (15 shared papers)Muhammad Ismail (16 shared papers)Chen Yao (14 shared papers)Qing Xia (6 shared papers)Jianing Zhao (3 shared papers)Yuan Du (3 shared papers)Zhenglin Fu (4 shared papers)
- Journals
- International Journal of Pharmaceutics (6 papers)Colloids and Surfaces B Biointerfaces (4 papers)European Journal of Pharmaceutical Sciences (2 papers)Journal of Drug Delivery Science and Technology (2 papers)Molecular Pharmaceutics (1 paper)
- Partner nations
- ChinaBangladeshSouth Korea
In The Last Decade
Longbing Ling
26 papers receiving 657 citations
Peers
Comparison fields: 5 of 93
- Biomaterials 264
- Pharmaceutical Science 66
- Molecular Medicine 27
- Molecular Biology 312
- Biomedical Engineering 190
Countries citing papers authored by Longbing Ling
This map shows the geographic impact of Longbing Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Longbing Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Longbing Ling more than expected).
Fields of papers citing papers by Longbing Ling
This network shows the impact of papers produced by Longbing Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Longbing Ling. The network helps show where Longbing Ling may publish in the future.
Co-authors
The 25 scholars most cited alongside Longbing Ling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 67 | |
| 2 | 2022 | 63 | |
| 3 | 2018 | 49 | |
| 4 | 2019 | 46 | |
| 5 | 2019 | 37 | |
| 6 | 2022 | 36 | |
| 7 | 2017 | 36 | |
| 8 | 2022 | 34 | |
| 9 | 2017 | 31 | |
| 10 | 2021 | 26 | |
| 11 | 2019 | 25 | |
| 12 | 2018 | 24 | |
| 13 | 2023 | 22 | |
| 14 | 2020 | 20 | |
| 15 | 2021 | 19 | |
| 16 | 2017 | 18 | |
| 17 | 2019 | 17 | |
| 18 | 2019 | 16 | |
| 19 | 2018 | 16 | |
| 20 | 2017 | 14 |
About Longbing Ling
Longbing Ling is a scholar working on Molecular Biology, Biomaterials, Biomedical Engineering, Organic Chemistry and Materials Chemistry, having authored 28 papers that have together received 663 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (13 papers), RNA Interference and Gene Delivery (11 papers), Nanoplatforms for cancer theranostics (7 papers), Lipid Membrane Structure and Behavior (6 papers), Dendrimers and Hyperbranched Polymers (3 papers), Advanced biosensing and bioanalysis techniques (2 papers), Cancer therapeutics and mechanisms (2 papers) and Retinoids in leukemia and cellular processes (2 papers). The work is most often cited by research in Biomaterials (264 citations), Pharmaceutical Science (66 citations), Molecular Medicine (27 citations), Molecular Biology (312 citations) and Biomedical Engineering (190 citations). Longbing Ling has collaborated with scholars based in China, Bangladesh and South Korea. Frequent co-authors include Xinsong Li, Yawei Du, Muhammad Ismail, Chen Yao, Qing Xia, Jianing Zhao, Yuan Du, Zhenglin Fu, Wenya Zhou and Wei He. Their work appears in journals such as International Journal of Pharmaceutics, Colloids and Surfaces B Biointerfaces, European Journal of Pharmaceutical Sciences, Journal of Drug Delivery Science and Technology and Molecular Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.